BiomX Inc. - Common Stock, $0.0001 par value per share (PHGE)

CUSIP: 09090D103

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 5 signals
Share change
-22,948,587
SEC-reported price per share
$1.02
Number of holders
2
Value change
-$9,565,291
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
11,618,400

Security key

09090D103

Report period

Q3 2024

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of PHGE - BiomX Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
OrbiMed Israel BioFund GP...
Disclosed value leader
OrbiMed Israel BioFund GP...
Comparable rows
0/15
Latest evidence
16 Sep 2024
3/4/5 13F Highest disclosed value: $5,250,517 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

OrbiMed Israel BioFund GP Limited Partnership has the largest disclosed position value at $5.25M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens OrbiMed Israel BioFund GP Limited Partnership's linked filing trail.
Disclosed position value Top 5
OrbiMed Israel BioFund GP Limited... $5.25M
Ugwumba Chidozie $1.02M
ORBIMED ADVISORS LLC $4.63M
DEERFIELD MANAGEMENT COMPANY, L.P. $2.05M
JOHNSON & JOHNSON $646.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
OrbiMed Israel BioFund GP Limited Partnership
3/4/5
10%+ Owner
—
mixed-class rows
$5,250,517
13,777,980 shares
mixed-class rows
— 15 May 2024
Ugwumba Chidozie
3/4/5
Exit Form 4 - former 10% owner
—
denominator unverified
$1,018,989
2,997,025 shares
— 17 Oct 2022
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$4,629,325
13,773,653 shares
— 30 Jun 2024
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$2,053,604
6,110,098 shares
— 30 Jun 2024
JOHNSON & JOHNSON
13F
Company
13F
—
denominator unverified
$646,388
1,923,201 shares
— 30 Jun 2024
8VC GP I, LLC
13F
Company
13F
—
denominator unverified
$365,069
1,086,191 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
300,942
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q3 2025 Across Filers

Q3 2025 holders
2
Q3 2024 holders
2
Holder diff
0
Investor Q3 2025 Shares Q3 2024 Shares Share Diff Share Chg % Q3 2025 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .